インスリン市場は、内分泌学における治療の中核を担っており、内因性β細胞分泌を模倣し、1型およびインスリン依存性2型糖尿病における血糖恒常性を調節する組換えヒトインスリン製剤およびアナログ製剤で構成されています。世界の推定によると、2024年には成人患者数は5億8,900万人に達し、2050年には46%増の8億5,300万人に達すると予測されています。その90%以上が2型糖尿病であり、その要因としては都市化、肥満、遺伝的要因が挙げられます。これらの注射剤は、安定した血糖値をカバーする長時間作用型基礎インスリン、食事時の血糖スパイクに対応する速効型ボーラスインスリン、二相性製剤の利便性を追求するプレミックスインスリン、そして従来のヒトインスリン製剤などがあり、動物抽出物からバイオシミラーに最適化されたプロファイルへと進化し、A1c値を1〜2%低下させ、低血糖リスクを5%未満に抑えています。市場の活況は、食後血糖コントロールのためのFiaspや、CGMを統合した自動投与のためのスマートペンといった超速効性類似薬、そしてGLP-1阻害薬の境界を曖昧にするRybelsusのような経口薬の登場によってもたらされています。バイオシミラーは先発医薬品のプレミアムを30〜50%削減し、80%のアンメットニーズが依然として存在する低所得国における医薬品へのアクセスを促進します。世界のインスリン市場は2025年までに150億米ドルから200億米ドルに達すると推定され、2030年までの年平均成長率（CAGR）は2.5%から4.5%と予測されています。この堅調な成長は、IDFの普及率予測、若年層における基礎ボーラス療法を優先するADA/EASDガイドライン、そして1日35ドルを上限とする価格ベースのインスリンポッドへの保険者の移行と一致しています。大手3社による90%のシェア寡占は規模の経済性を強調していますが、アジアのジェネリック医薬品は20%安価なヒトインスリンで対抗しています。インスリンは糖尿病の慢性管理を体現するものであり、厳格な管理によって平均余命を10年延ばしますが、注射針恐怖症などの服薬遵守の障壁が40%に影響を与えています。
インスリン市場はタイプ別に区分されており、それぞれのタイプは薬物動態ニーズとライフスタイルへの統合に合わせてカスタマイズされており、クローズドループシステムを推進しています。
インスリンバリューチェーンは、大腸菌による発現から接着エコシステムに至るまで、微生物発酵と精密送達を融合しています。上流の研究開発部門では、誘導進化法を用いて酵母のアナログ改変を行い、ノボはCRISPR技術の改良によりデグルデクを開発しました。ADAエンドポイントに基づく第III相試験には5億ドルの費用がかかりますが、希少小児疾患への適応により相殺されています。臨床開発部門では、CGM指標を用いたHCL試験を実施し、FDAのQIDP（医薬品開発プログラム）はバイオシミラーの迅速承認を促進しています。中流のバイオプロセス部門では、ピキア菌を10g/Lで培養し、封入体をリフォールディングすることで純度98%を実現しています。カートリッジへの充填・仕上げ工程ではレーザー溶接を採用し、インドのCMOはコストを40%削減しています。製剤は亜鉛を介してリスプロヘキサマーを安定化し、バイアル／ペンはDSCSAに基づいてシリアル番号が付けられています。下流の物流部門では、薬局への2〜8℃ハブを活用し、リリーは直送便で品薄を緩和しています。マーケティング部門は、DCCTのレガシーに関するKOLシンポジウムを開催し、ICERの5万ドル/QALYを通じたHEORを実施しています。サポートには、注射針交換やmySugrなどのアプリ、脂肪肥大症に対するFAERSを通じた医薬品安全性監視が含まれます。Novoのような寡占企業は、株バンキングからRWEまでを統合し、不足への対策を強化しています。
目次
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Insulin Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Insulin Market in North America (2020-2030)
8.1 Insulin Market Size
8.2 Insulin Market by End Use
8.3 Competition by Players/Suppliers
8.4 Insulin Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Insulin Market in South America (2020-2030)
9.1 Insulin Market Size
9.2 Insulin Market by End Use
9.3 Competition by Players/Suppliers
9.4 Insulin Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Insulin Market in Asia & Pacific (2020-2030)
10.1 Insulin Market Size
10.2 Insulin Market by End Use
10.3 Competition by Players/Suppliers
10.4 Insulin Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Insulin Market in Europe (2020-2030)
11.1 Insulin Market Size
11.2 Insulin Market by End Use
11.3 Competition by Players/Suppliers
11.4 Insulin Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Insulin Market in MEA (2020-2030)
12.1 Insulin Market Size
12.2 Insulin Market by End Use
12.3 Competition by Players/Suppliers
12.4 Insulin Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Insulin Market (2020-2025)
13.1 Insulin Market Size
13.2 Insulin Market by End Use
13.3 Competition by Players/Suppliers
13.4 Insulin Market Size by Type
Chapter 14 Global Insulin Market Forecast (2025-2030)
14.1 Insulin Market Size Forecast
14.2 Insulin Application Forecast
14.3 Competition by Players/Suppliers
14.4 Insulin Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 Novo Nordisk
15.1.1 Company Profile
15.1.2 Main Business and Insulin Information
15.1.3 SWOT Analysis of Novo Nordisk
15.1.4 Novo Nordisk Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.2 Eli Lilly
15.2.1 Company Profile
15.2.2 Main Business and Insulin Information
15.2.3 SWOT Analysis of Eli Lilly
15.2.4 Eli Lilly Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.3 Sanofi
15.3.1 Company Profile
15.3.2 Main Business and Insulin Information
15.3.3 SWOT Analysis of Sanofi
15.3.4 Sanofi Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.4 Biocon Biologics Inc.
15.4.1 Company Profile
15.4.2 Main Business and Insulin Information
15.4.3 SWOT Analysis of Biocon Biologics Inc.
15.4.4 Biocon Biologics Inc. Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.5 BIOTON S.A.
15.5.1 Company Profile
15.5.2 Main Business and Insulin Information
15.5.3 SWOT Analysis of BIOTON S.A.
15.5.4 BIOTON S.A. Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.6 Gan & Lee Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and Insulin Information
15.6.3 SWOT Analysis of Gan & Lee Pharmaceuticals
15.6.4 Gan & Lee Pharmaceuticals Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.7 Zhuhai United Laboratories
15.7.1 Company Profile
15.7.2 Main Business and Insulin Information
15.7.3 SWOT Analysis of Zhuhai United Laboratories
15.7.4 Zhuhai United Laboratories Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.8 Tonghua Dongbao Pharmaceutical
15.8.1 Company Profile
15.8.2 Main Business and Insulin Information
15.8.3 SWOT Analysis of Tonghua Dongbao Pharmaceutical
15.8.4 Tonghua Dongbao Pharmaceutical Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.9 Zhejiang Hisun Pharmaceutical
15.9.1 Company Profile
15.9.2 Main Business and Insulin Information
15.9.3 SWOT Analysis of Zhejiang Hisun Pharmaceutical
15.9.4 Zhejiang Hisun Pharmaceutical Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.10 Fosun Wanbang Pharma Group
15.10.1 Company Profile
15.10.2 Main Business and Insulin Information
15.10.3 SWOT Analysis of Fosun Wanbang Pharma Group
15.10.4 Fosun Wanbang Pharma Group Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.11 Wockhardt
15.11.1 Company Profile
15.11.2 Main Business and Insulin Information
15.11.3 SWOT Analysis of Wockhardt
15.11.4 Wockhardt Insulin Revenue, Gross Margin and Market Share (2020-2025)
15.12 Julphar
15.12.1 Company Profile
15.12.2 Main Business and Insulin Information
15.12.3 SWOT Analysis of Julphar
15.12.4 Julphar Insulin Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Insulin Report
Table Data Sources of Insulin Report
Table Major Assumptions of Insulin Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Insulin Picture
Table Insulin Classification
Table Insulin Applications
Table Drivers of Insulin Market
Table Restraints of Insulin Market
Table Opportunities of Insulin Market
Table Threats of Insulin Market
Table COVID-19 Impact for Insulin Market
Table Raw Materials Suppliers
Table Different Production Methods of Insulin
Table Cost Structure Analysis of Insulin
Table Key End Users
Table Latest News of Insulin Market
Table Merger and Acquisition
Table Planned/Future Project of Insulin Market
Table Policy of Insulin Market
Table 2020-2030 North America Insulin Market Size
Figure 2020-2030 North America Insulin Market Size and CAGR
Table 2020-2030 North America Insulin Market Size by Application
Table 2020-2025 North America Insulin Key Players Revenue
Table 2020-2025 North America Insulin Key Players Market Share
Table 2020-2030 North America Insulin Market Size by Type
Table 2020-2030 United States Insulin Market Size
Table 2020-2030 Canada Insulin Market Size
Table 2020-2030 Mexico Insulin Market Size
Table 2020-2030 South America Insulin Market Size
Figure 2020-2030 South America Insulin Market Size and CAGR
Table 2020-2030 South America Insulin Market Size by Application
Table 2020-2025 South America Insulin Key Players Revenue
Table 2020-2025 South America Insulin Key Players Market Share
Table 2020-2030 South America Insulin Market Size by Type
Table 2020-2030 Brazil Insulin Market Size
Table 2020-2030 Argentina Insulin Market Size
Table 2020-2030 Chile Insulin Market Size
Table 2020-2030 Peru Insulin Market Size
Table 2020-2030 Asia & Pacific Insulin Market Size
Figure 2020-2030 Asia & Pacific Insulin Market Size and CAGR
Table 2020-2030 Asia & Pacific Insulin Market Size by Application
Table 2020-2025 Asia & Pacific Insulin Key Players Revenue
Table 2020-2025 Asia & Pacific Insulin Key Players Market Share
Table 2020-2030 Asia & Pacific Insulin Market Size by Type
Table 2020-2030 China Insulin Market Size
Table 2020-2030 India Insulin Market Size
Table 2020-2030 Japan Insulin Market Size
Table 2020-2030 South Korea Insulin Market Size
Table 2020-2030 Southeast Asia Insulin Market Size
Table 2020-2030 Australia Insulin Market Size
Table 2020-2030 Europe Insulin Market Size
Figure 2020-2030 Europe Insulin Market Size and CAGR
Table 2020-2030 Europe Insulin Market Size by Application
Table 2020-2025 Europe Insulin Key Players Revenue
Table 2020-2025 Europe Insulin Key Players Market Share
Table 2020-2030 Europe Insulin Market Size by Type
Table 2020-2030 Germany Insulin Market Size
Table 2020-2030 France Insulin Market Size
Table 2020-2030 United Kingdom Insulin Market Size
Table 2020-2030 Italy Insulin Market Size
Table 2020-2030 Spain Insulin Market Size
Table 2020-2030 Belgium Insulin Market Size
Table 2020-2030 Netherlands Insulin Market Size
Table 2020-2030 Austria Insulin Market Size
Table 2020-2030 Poland Insulin Market Size
Table 2020-2030 Russia Insulin Market Size
Table 2020-2030 MEA Insulin Market Size
Figure 2020-2030 MEA Insulin Market Size and CAGR
Table 2020-2030 MEA Insulin Market Size by Application
Table 2020-2025 MEA Insulin Key Players Revenue
Table 2020-2025 MEA Insulin Key Players Market Share
Table 2020-2030 MEA Insulin Market Size by Type
Table 2020-2030 Egypt Insulin Market Size
Table 2020-2030 Israel Insulin Market Size
Table 2020-2030 South Africa Insulin Market Size
Table 2020-2030 Gulf Cooperation Council Countries Insulin Market Size
Table 2020-2030 Turkey Insulin Market Size
Table 2020-2025 Global Insulin Market Size by Region
Table 2020-2025 Global Insulin Market Size Share by Region
Table 2020-2025 Global Insulin Market Size by Application
Table 2020-2025 Global Insulin Market Share by Application
Table 2020-2025 Global Insulin Key Vendors Revenue
Figure 2020-2025 Global Insulin Market Size and Growth Rate
Table 2020-2025 Global Insulin Key Vendors Market Share
Table 2020-2025 Global Insulin Market Size by Type
Table 2020-2025 Global Insulin Market Share by Type
Table 2025-2030 Global Insulin Market Size by Region
Table 2025-2030 Global Insulin Market Size Share by Region
Table 2025-2030 Global Insulin Market Size by Application
Table 2025-2030 Global Insulin Market Share by Application
Table 2025-2030 Global Insulin Key Vendors Revenue
Figure 2025-2030 Global Insulin Market Size and Growth Rate
Table 2025-2030 Global Insulin Key Vendors Market Share
Table 2025-2030 Global Insulin Market Size by Type
Table 2025-2030 Insulin Global Market Share by Type
Table Novo Nordisk Information
Table SWOT Analysis of Novo Nordisk
Table 2020-2025 Novo Nordisk Insulin Revenue Gross Profit Margin
Figure 2020-2025 Novo Nordisk Insulin Revenue and Growth Rate
Figure 2020-2025 Novo Nordisk Insulin Market Share
Table Eli Lilly Information
Table SWOT Analysis of Eli Lilly
Table 2020-2025 Eli Lilly Insulin Revenue Gross Profit Margin
Figure 2020-2025 Eli Lilly Insulin Revenue and Growth Rate
Figure 2020-2025 Eli Lilly Insulin Market Share
Table Sanofi Information
Table SWOT Analysis of Sanofi
Table 2020-2025 Sanofi Insulin Revenue Gross Profit Margin
Figure 2020-2025 Sanofi Insulin Revenue and Growth Rate
Figure 2020-2025 Sanofi Insulin Market Share
Table Biocon Biologics Inc. Information
Table SWOT Analysis of Biocon Biologics Inc.
Table 2020-2025 Biocon Biologics Inc. Insulin Revenue Gross Profit Margin
Figure 2020-2025 Biocon Biologics Inc. Insulin Revenue and Growth Rate
Figure 2020-2025 Biocon Biologics Inc. Insulin Market Share
Table BIOTON S.A. Information
Table SWOT Analysis of BIOTON S.A.
Table 2020-2025 BIOTON S.A. Insulin Revenue Gross Profit Margin
Figure 2020-2025 BIOTON S.A. Insulin Revenue and Growth Rate
Figure 2020-2025 BIOTON S.A. Insulin Market Share
Table Gan & Lee Pharmaceuticals Information
Table SWOT Analysis of Gan & Lee Pharmaceuticals
Table 2020-2025 Gan & Lee Pharmaceuticals Insulin Revenue Gross Profit Margin
Figure 2020-2025 Gan & Lee Pharmaceuticals Insulin Revenue and Growth Rate
Figure 2020-2025 Gan & Lee Pharmaceuticals Insulin Market Share
Table Zhuhai United Laboratories Information
Table SWOT Analysis of Zhuhai United Laboratories
Table 2020-2025 Zhuhai United Laboratories Insulin Revenue Gross Profit Margin
Figure 2020-2025 Zhuhai United Laboratories Insulin Revenue and Growth Rate
Figure 2020-2025 Zhuhai United Laboratories Insulin Market Share
Table Tonghua Dongbao Pharmaceutical Information
Table SWOT Analysis of Tonghua Dongbao Pharmaceutical
Table 2020-2025 Tonghua Dongbao Pharmaceutical Insulin Revenue Gross Profit Margin
Figure 2020-2025 Tonghua Dongbao Pharmaceutical Insulin Revenue and Growth Rate
Figure 2020-2025 Tonghua Dongbao Pharmaceutical Insulin Market Share
Table Zhejiang Hisun Pharmaceutical Information
Table SWOT Analysis of Zhejiang Hisun Pharmaceutical
Table 2020-2025 Zhejiang Hisun Pharmaceutical Insulin Revenue Gross Profit Margin
Figure 2020-2025 Zhejiang Hisun Pharmaceutical Insulin Revenue and Growth Rate
Figure 2020-2025 Zhejiang Hisun Pharmaceutical Insulin Market Share
Table Fosun Wanbang Pharma Group Information
Table SWOT Analysis of Fosun Wanbang Pharma Group
Table 2020-2025 Fosun Wanbang Pharma Group Insulin Revenue Gross Profit Margin
Figure 2020-2025 Fosun Wanbang Pharma Group Insulin Revenue and Growth Rate
Figure 2020-2025 Fosun Wanbang Pharma Group Insulin Market Share
Table Wockhardt Information
Table SWOT Analysis of Wockhardt
Table 2020-2025 Wockhardt Insulin Revenue Gross Profit Margin
Figure 2020-2025 Wockhardt Insulin Revenue and Growth Rate
Figure 2020-2025 Wockhardt Insulin Market Share
Table Julphar Information
Table SWOT Analysis of Julphar
Table 2020-2025 Julphar Insulin Revenue Gross Profit Margin
Figure 2020-2025 Julphar Insulin Revenue and Growth Rate
Figure 2020-2025 Julphar Insulin Market Share
......
